DK2639296T3 - Stamcellesuspension - Google Patents
Stamcellesuspension Download PDFInfo
- Publication number
- DK2639296T3 DK2639296T3 DK11839155.6T DK11839155T DK2639296T3 DK 2639296 T3 DK2639296 T3 DK 2639296T3 DK 11839155 T DK11839155 T DK 11839155T DK 2639296 T3 DK2639296 T3 DK 2639296T3
- Authority
- DK
- Denmark
- Prior art keywords
- stem cells
- cell
- trehalose
- cells
- dextran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/02—Esters
- C08B31/04—Esters of organic acids, e.g. alkenyl-succinated starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Claims (3)
1. Anvendelse af mindst ét polysaccharid valgt fra gruppen bestående af trehalose, hydroxyethylstivelse og dextran som en aggregerings-inhibitor for pattedyr-stamceller i en pattedyr-stamcellesuspension, hvori, - når polysaccharidet er trehalose, da anvendes inhibitoren sådan at koncentrationen af trehalose i pattedyr-stamcellesuspensionen er inden for området på 4,53 - 362,4 mg/ml; - når polysaccharidet er hydroxyethylstivelse, da anvendes inhibitoren sådan at koncentrationen af hydroxyethylstivelse i pattedyr-stamcellesuspensionen er inden for området på 1 - 500 mg/ml; - og når polysaccharidet er dextran, da anvendes inhibitoren sådan at koncentrationen af dextran i pattedyr-stamcellesuspensionen er inden for området på 30 - 100 mg/ml.
2. Anvendelse ifølge krav 1, hvor stamcellen er en adhæsiv stamcelle.
3. Anvendelse ifølge krav 2, hvor den adhæsive stamcelle er en mesenchymal stamcelle eller en pluripotent stamcelle.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010251273 | 2010-11-09 | ||
JP2010293908A JP5341059B2 (ja) | 2010-11-09 | 2010-12-28 | 幹細胞懸濁液 |
PCT/JP2011/075843 WO2012063870A1 (ja) | 2010-11-09 | 2011-11-09 | 幹細胞懸濁液 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2639296T3 true DK2639296T3 (da) | 2016-04-25 |
Family
ID=46051010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11839155.6T DK2639296T3 (da) | 2010-11-09 | 2011-11-09 | Stamcellesuspension |
Country Status (15)
Country | Link |
---|---|
US (1) | US10087421B2 (da) |
EP (1) | EP2639296B1 (da) |
JP (1) | JP5341059B2 (da) |
KR (1) | KR101868653B1 (da) |
CN (1) | CN103298926B (da) |
AU (1) | AU2011327239B2 (da) |
CA (1) | CA2817172C (da) |
CY (1) | CY1117419T1 (da) |
DK (1) | DK2639296T3 (da) |
ES (1) | ES2568731T3 (da) |
NZ (1) | NZ610556A (da) |
SG (1) | SG190169A1 (da) |
SI (1) | SI2639296T1 (da) |
TW (1) | TWI547561B (da) |
WO (1) | WO2012063870A1 (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5432322B2 (ja) * | 2012-05-08 | 2014-03-05 | 株式会社大塚製薬工場 | トレハロース含有肺塞栓形成予防用哺乳動物細胞懸濁液 |
JP5196618B1 (ja) * | 2012-09-28 | 2013-05-15 | 株式会社大塚製薬工場 | トレハロース含有細胞洗浄溶液を用いた接着細胞の洗浄方法 |
JP5276230B1 (ja) * | 2013-01-10 | 2013-08-28 | 株式会社大塚製薬工場 | トレハロース含有細胞洗浄溶液を用いた接着細胞のインビトロ継代方法 |
SG11201510045TA (en) * | 2013-06-28 | 2016-01-28 | Otsuka Pharma Co Ltd | Trehalose and dextran-containing solution for transplanting mammalian cells |
CA2921948C (en) * | 2013-09-04 | 2019-11-19 | Otsuka Pharmaceutical Factory, Inc. | Method for preparing pluripotent stem cells |
EP3052943B1 (en) * | 2013-10-04 | 2019-11-20 | Cell Ideas Pty Ltd. | Biomarkers for cell therapy |
BR112017006533A2 (pt) * | 2014-09-29 | 2017-12-19 | Cook General Biotechnology Llc | usos de trealose em suspensões celulares |
US20160324898A1 (en) * | 2015-05-04 | 2016-11-10 | Stemedica International, Sa | Compositions and methods for the treatment of alzheimer's disease |
CN105267952B (zh) * | 2015-09-01 | 2018-05-18 | 河南卓丰生物科技有限公司 | 一种用于保护干细胞治疗的药物及其制备方法 |
CA3022685A1 (en) * | 2016-03-28 | 2017-10-05 | Cook General Biotechnology Llc | Methods of cryopreservation of viable cells, compositions of viable cells and uses thereof |
CZ306800B6 (cs) * | 2016-05-13 | 2017-07-12 | Ústav experimentální medicíny AV ČR, v. v. i. | Prostředek pro uchování, transport a aplikaci kmenových buněk |
CZ2016644A3 (cs) * | 2016-10-14 | 2018-06-06 | Ústav experimentální medicíny AV ČR, v. v. i. | Prostředek obsahující kmenové buňky k léčení posttraumatických zánětlivých reakcí a způsob jeho výroby |
CN107034184A (zh) * | 2017-05-04 | 2017-08-11 | 济南赛尔生物科技股份有限公司 | 一种用于原代培养脐带间充质干细胞的试剂盒 |
CN107156108A (zh) * | 2017-05-27 | 2017-09-15 | 魏方萌 | 一种外周血干细胞保存液及制备方法 |
WO2018225673A1 (ja) * | 2017-06-06 | 2018-12-13 | Dsファーマアニマルヘルス株式会社 | 細胞凝集低減方法および細胞凝集が低減された治療用組成物 |
CN107912420A (zh) * | 2017-10-27 | 2018-04-17 | 北京协科医药科技有限公司 | 一种细胞保存方法、保存液及保存液制备方法 |
AU2019345595A1 (en) | 2018-09-28 | 2021-04-15 | Otsuka Pharmaceutical Factory,Inc. | Mammal cell preserving solution containing acarbose or stachyose |
CA3129733A1 (en) | 2019-03-15 | 2020-09-24 | Junko TOMIZUKA | Storage liquid for mammalian cells |
TW202106870A (zh) | 2019-04-26 | 2021-02-16 | 日商大塚製藥工場股份有限公司 | 包含海藻醣之哺乳動物細胞保存用液 |
JP7079045B2 (ja) * | 2020-01-17 | 2022-06-01 | 株式会社大塚製薬工場 | トレハロースを含む血球系細胞保存用液 |
WO2021193606A1 (ja) * | 2020-03-27 | 2021-09-30 | 株式会社大塚製薬工場 | アカルボース及びデキストランを含む哺乳動物細胞保存用液 |
CN114574426A (zh) * | 2022-01-25 | 2022-06-03 | 湖北省农业科学院畜牧兽医研究所 | 一种鸭小肠隐窝干细胞分离鉴定和3d类器官培养的方法 |
CN115039762B (zh) * | 2022-06-17 | 2023-04-11 | 广州沙艾生物科技有限公司 | 一种胎盘干细胞储存液及储存方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004681B1 (en) * | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
JP3253131B2 (ja) | 1992-07-24 | 2002-02-04 | 洋巳 和田 | 移植臓器用溶液 |
EP0762897B1 (en) * | 1994-06-02 | 2003-04-02 | Elan Drug Delivery Limited | Method of preventing aggregation of proteins/peptides upon rehydration or thawing |
AU4330597A (en) * | 1996-08-30 | 1998-03-19 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
JPH114682A (ja) * | 1997-06-16 | 1999-01-12 | Asahi Medical Co Ltd | 有核細胞保存方法、有核細胞保存用組成物及び有核細胞分離方法 |
US20060257842A1 (en) * | 2003-05-29 | 2006-11-16 | Pettegrew Jay W | Cryopreservation media and molecules |
US20050048460A1 (en) * | 2003-05-29 | 2005-03-03 | The Regents Of The University Of California | Preservative and method for preserving cells |
US20060009469A1 (en) * | 2004-05-28 | 2006-01-12 | Leonore Witchey-Lakshmanan | Particulate-stabilized injectable pharmacutical compositions of posaconazole |
US7880925B2 (en) | 2005-08-02 | 2011-02-01 | Kabushiki Kaisha Toshiba | Apparatus and method for generating an image file with a color layer and a monochrome layer |
JP5274017B2 (ja) | 2005-10-13 | 2013-08-28 | 株式会社大塚製薬工場 | 肝臓保存液 |
CN101374941A (zh) * | 2005-12-29 | 2009-02-25 | 人类起源公司 | 采集和保存胎盘干细胞的改良组合物及其使用方法 |
EP2278873B1 (en) * | 2008-03-19 | 2015-05-06 | Cryo-Save AG | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells |
JP2009296889A (ja) * | 2008-06-10 | 2009-12-24 | Foundation For Biomedical Research & Innovation | 造血幹細胞の培養方法 |
US20100035327A1 (en) | 2008-08-11 | 2010-02-11 | Ann Marie Steele | Use of rice-derived products in a universal cell culture medium |
KR20200011604A (ko) * | 2008-08-20 | 2020-02-03 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
US20110208162A1 (en) * | 2008-10-24 | 2011-08-25 | Indiana University Rsearch and Technology Corporation | Methods for preventing aggregation of adipose stromal cells |
CN102281903B (zh) * | 2008-11-17 | 2013-11-13 | 弗·哈夫曼-拉罗切有限公司 | 降低大分子在生理条件下聚集的方法和配方 |
JP6027300B2 (ja) * | 2009-03-19 | 2016-11-16 | 国立大学法人岩手大学 | 細胞または臓器の保存液および保存方法 |
-
2010
- 2010-12-28 JP JP2010293908A patent/JP5341059B2/ja active Active
-
2011
- 2011-11-09 AU AU2011327239A patent/AU2011327239B2/en active Active
- 2011-11-09 EP EP11839155.6A patent/EP2639296B1/en active Active
- 2011-11-09 ES ES11839155.6T patent/ES2568731T3/es active Active
- 2011-11-09 WO PCT/JP2011/075843 patent/WO2012063870A1/ja active Application Filing
- 2011-11-09 NZ NZ61055611A patent/NZ610556A/en not_active IP Right Cessation
- 2011-11-09 CA CA2817172A patent/CA2817172C/en active Active
- 2011-11-09 KR KR1020137014704A patent/KR101868653B1/ko active IP Right Grant
- 2011-11-09 DK DK11839155.6T patent/DK2639296T3/da active
- 2011-11-09 US US13/883,371 patent/US10087421B2/en active Active
- 2011-11-09 TW TW100140841A patent/TWI547561B/zh active
- 2011-11-09 SI SI201130786A patent/SI2639296T1/sl unknown
- 2011-11-09 CN CN201180064550.4A patent/CN103298926B/zh active Active
- 2011-11-09 SG SG2013034681A patent/SG190169A1/en unknown
-
2016
- 2016-04-26 CY CY20161100342T patent/CY1117419T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2817172A1 (en) | 2012-05-18 |
ES2568731T3 (es) | 2016-05-04 |
US10087421B2 (en) | 2018-10-02 |
JP5341059B2 (ja) | 2013-11-13 |
CN103298926B (zh) | 2017-11-03 |
SI2639296T1 (sl) | 2016-09-30 |
CY1117419T1 (el) | 2017-04-26 |
EP2639296A4 (en) | 2014-04-30 |
AU2011327239B2 (en) | 2016-11-17 |
AU2011327239A1 (en) | 2013-06-20 |
CN103298926A (zh) | 2013-09-11 |
EP2639296B1 (en) | 2016-02-03 |
JP2012115253A (ja) | 2012-06-21 |
SG190169A1 (en) | 2013-06-28 |
TWI547561B (zh) | 2016-09-01 |
TW201226568A (en) | 2012-07-01 |
CA2817172C (en) | 2021-05-18 |
NZ610556A (en) | 2015-03-27 |
EP2639296A1 (en) | 2013-09-18 |
US20130260461A1 (en) | 2013-10-03 |
KR20130129382A (ko) | 2013-11-28 |
WO2012063870A1 (ja) | 2012-05-18 |
KR101868653B1 (ko) | 2018-06-18 |
AU2011327239A8 (en) | 2013-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2639296T3 (da) | Stamcellesuspension | |
JP5998265B2 (ja) | トレハロース及びデキストラン含有哺乳動物細胞移植用溶液 | |
RU2756561C2 (ru) | Среда для формирования колоний и её применение | |
KR20190055790A (ko) | 세포 배양 배지를 사용한 제대 양막(umbilical cord amniotic membrane)으로부터 중간엽 줄기세포를 분리하는 방법 | |
ES2807897T3 (es) | Terapia con células madre basada en células madre procedentes de tejido adiposo | |
JP5432322B2 (ja) | トレハロース含有肺塞栓形成予防用哺乳動物細胞懸濁液 | |
JP5753874B2 (ja) | 細胞生存率低下抑制剤 | |
JP6830294B1 (ja) | トレハロースを含む哺乳動物細胞保存用液 | |
JP2013252126A (ja) | デキストラン含有肺塞栓形成予防用哺乳動物細胞懸濁液 | |
WO2021193606A1 (ja) | アカルボース及びデキストランを含む哺乳動物細胞保存用液 | |
JP2023148207A (ja) | 細胞製剤用非凍結保存液 |